| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |